美國居民不適用 XM 服務。

Cerebras likely to postpone IPO due to CFIUS review delay on G42 deal, sources say



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EXCLUSIVE-Cerebras likely to postpone IPO due to CFIUS review delay on G42 deal, sources say</title></head><body>

Cerebras likely to postpone IPO due to CFIUS review delay

CFIUS reviewing G42's investment in Cerebras

G42 business accounted for 83% of Cerebras' 2023 revenue

Cerebras and G42 amended filing to specify non-voting securities

Adds more background on Cerebras

By Echo Wang, Max A. Cherney and Krystal Hu

NEW YORK, Oct 8 (Reuters) -Cerebras Systems is likely to postpone its IPO, after facing delays with a U.S. national security review on UAE-based tech conglomerate G42's minority investment in the AI chipmaker, people familiar with the matter said on Tuesday.

Cerebras, which competes with industry leader Nvidia NVDA.O in the lucrative artificial intelligence chip market, is likely to call off the roadshow that was scheduled for early next week for its highly anticipated initial public offering, the sources said, requesting anonymity as the discussions are confidential.

Cerebras declined to comment. G42 did not respond to requests for comment.

The Committee on Foreign Investment in the United States (CFIUS), which reviews foreign investments over possible national security concerns, is currently looking into G42's investment in Cerebras, the company disclosed in a recent regulatory filing.

Cerebras still expects CFIUS to green-light the G42 deal this year, the sources said. The company will look to proceed with a stock market launch as soon as it receives the necessary clearance from CFIUS, the sources said, cautioning that the plans could change depending on the timing of the approval.

A spokesperson for the U.S. Treasury, which is in charge of CFIUS, declined to comment on the Cerebras IPO, saying that the agency is "committed to taking all necessary actions within its authority to safeguard U.S. national security."

UAE-based technology group G42, which is an investor and the biggest client of Cerebras, has drawn increased scrutiny from China hawks in Washington, amid fears that the UAE and other Middle Eastern companies are becoming a conduit for China to receive advanced American AI technology it is blocked from getting directly from the United States.

Business from G42 accounted for $65.1 million, or 83%, of the total revenue for Cerebras during the year ended December 31, 2023, according to the filing. For the six months ended June 30, Cerebras reported total revenue of $136.4 million, compared to $8.7 million a year earlier.

G42 has committed to buy $335 million worth of Cerebras' stock by April, a deal that would give it a stake of more than 5% in the company.

REVIEW DELAYS

Cerebras and G42 have submitted a joint filing to notify CFIUS of the investment. The companies later amended the filing, specifying that the shares to be acquired by G42 will be non-voting securities, which they argued should not require a CFIUS review.

In September, the companies submitted a request to CFIUS to withdraw the notice. CFIUS is considering the withdrawal request, according to Cerebras' IPO filing.

Sunnyvale, California-based Cerebras, which was valued at about $4 billion in a funding round in 2021, is in the process of building a series of AI data centers for G42. The technology developed by Cerebras has been used to train an Arabic large language model, which is now being served on the Microsoft Azure AI platform.

The processors developed by Cerebras compete directly with the chips made by Nvidia for building large artificial intelligence models and running AI applications. The chip startup is one of the few in Silicon Valley that is adopting a different technical strategy than Nvidia to tackle the same computing challenge faced by customers.

Cerebras CEO Andrew Feldman has previously claimed that the large chip produced by Cerebras carries several technical advantages for AI applications, compared to chips produced by Nvidia and other competitors.

Cerebras tapped Citigroup and Barclays as the lead underwriters for the planned offering.



Reporting by Echo Wang in New York, Max Cherney and Krystal Hu in San Francisco; additional reporting by Alexandra Alper; Editing by Anirban Sen and Nick Zieminski

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明